 Colleen Julian
Concepts (393)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 57 | 2025 | 463 | 10.340 |
Why?
| | Pre-Eclampsia | 15 | 2025 | 206 | 4.540 |
Why?
| | Fetal Growth Retardation | 25 | 2025 | 593 | 3.890 |
Why?
| | Placenta | 13 | 2025 | 787 | 3.860 |
Why?
| | AMP-Activated Protein Kinases | 9 | 2025 | 192 | 3.380 |
Why?
| | Uterine Artery | 15 | 2024 | 74 | 2.880 |
Why?
| | Hypoxia | 27 | 2024 | 1199 | 2.760 |
Why?
| | Adaptation, Physiological | 14 | 2025 | 560 | 2.640 |
Why?
| | Fetal Hypoxia | 8 | 2024 | 56 | 2.430 |
Why?
| | Pregnancy | 63 | 2025 | 7215 | 2.360 |
Why?
| | Altitude Sickness | 15 | 2022 | 141 | 2.250 |
Why?
| | Fetal Development | 9 | 2025 | 298 | 2.020 |
Why?
| | Placental Circulation | 9 | 2025 | 71 | 1.820 |
Why?
| | Acclimatization | 13 | 2019 | 170 | 1.710 |
Why?
| | Bolivia | 19 | 2025 | 63 | 1.550 |
Why?
| | PPAR gamma | 3 | 2020 | 182 | 1.470 |
Why?
| | Oxygen | 17 | 2025 | 981 | 1.460 |
Why?
| | Birth Weight | 13 | 2024 | 517 | 1.420 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 74 | 0.920 |
Why?
| | Hypertension, Pregnancy-Induced | 5 | 2023 | 69 | 0.900 |
Why?
| | Selection, Genetic | 7 | 2019 | 263 | 0.890 |
Why?
| | Pregnancy Outcome | 4 | 2019 | 504 | 0.850 |
Why?
| | Hemodynamics | 4 | 2024 | 1118 | 0.840 |
Why?
| | Pregnancy Complications | 5 | 2017 | 603 | 0.830 |
Why?
| | Female | 79 | 2025 | 79025 | 0.820 |
Why?
| | Endothelin-1 | 2 | 2020 | 181 | 0.800 |
Why?
| | Biology | 1 | 2023 | 89 | 0.730 |
Why?
| | Fatty Acids | 1 | 2025 | 457 | 0.730 |
Why?
| | Hypertension, Pulmonary | 3 | 2025 | 1957 | 0.710 |
Why?
| | Uterus | 4 | 2020 | 228 | 0.700 |
Why?
| | Infant, Newborn | 16 | 2025 | 6464 | 0.670 |
Why?
| | Sympathetic Nervous System | 6 | 2020 | 181 | 0.620 |
Why?
| | Gestational Age | 12 | 2024 | 989 | 0.620 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 138 | 0.620 |
Why?
| | Humans | 85 | 2025 | 145750 | 0.610 |
Why?
| | Regional Blood Flow | 8 | 2024 | 514 | 0.610 |
Why?
| | Neovascularization, Physiologic | 1 | 2021 | 193 | 0.590 |
Why?
| | Adult | 48 | 2025 | 40867 | 0.580 |
Why?
| | Polycythemia | 3 | 2017 | 25 | 0.570 |
Why?
| | Erythropoietin | 3 | 2017 | 100 | 0.540 |
Why?
| | Pulmonary Circulation | 2 | 2021 | 430 | 0.520 |
Why?
| | Vascular Diseases | 2 | 2017 | 252 | 0.500 |
Why?
| | Receptors, Erythropoietin | 1 | 2017 | 21 | 0.500 |
Why?
| | Signal Transduction | 5 | 2025 | 5223 | 0.500 |
Why?
| | Heart Defects, Congenital | 1 | 2025 | 910 | 0.490 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 693 | 0.480 |
Why?
| | Fetus | 5 | 2025 | 804 | 0.460 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2601 | 0.450 |
Why?
| | Infant, Small for Gestational Age | 3 | 2011 | 118 | 0.450 |
Why?
| | Case-Control Studies | 9 | 2024 | 3634 | 0.450 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2023 | 552 | 0.450 |
Why?
| | Enzymes | 2 | 2013 | 60 | 0.440 |
Why?
| | Arteries | 3 | 2022 | 261 | 0.430 |
Why?
| | Vasodilation | 4 | 2022 | 521 | 0.420 |
Why?
| | Young Adult | 20 | 2024 | 14250 | 0.390 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2021 | 655 | 0.390 |
Why?
| | DNA Methylation | 2 | 2023 | 690 | 0.350 |
Why?
| | Blood Proteins | 1 | 2013 | 239 | 0.350 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 98 | 0.350 |
Why?
| | Antioxidants | 2 | 2013 | 550 | 0.340 |
Why?
| | Vascular Resistance | 5 | 2024 | 370 | 0.340 |
Why?
| | Middle Cerebral Artery | 3 | 2024 | 56 | 0.340 |
Why?
| | Oxygen Consumption | 2 | 2011 | 719 | 0.330 |
Why?
| | Hemoglobins | 7 | 2017 | 386 | 0.330 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 88 | 0.330 |
Why?
| | Infant, Low Birth Weight | 2 | 2011 | 156 | 0.330 |
Why?
| | Erythrocytes | 4 | 2017 | 749 | 0.320 |
Why?
| | Phenotype | 3 | 2025 | 3170 | 0.310 |
Why?
| | Biological Evolution | 2 | 2015 | 468 | 0.310 |
Why?
| | Erythropoiesis | 2 | 2014 | 57 | 0.300 |
Why?
| | Placental Insufficiency | 2 | 2023 | 126 | 0.300 |
Why?
| | Oxidative Stress | 2 | 2013 | 1359 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 8 | 2019 | 2181 | 0.290 |
Why?
| | Lung Diseases | 1 | 2015 | 782 | 0.280 |
Why?
| | Women's Health | 1 | 2011 | 316 | 0.280 |
Why?
| | Cerebrovascular Circulation | 4 | 2024 | 290 | 0.280 |
Why?
| | Fertility | 1 | 2009 | 174 | 0.270 |
Why?
| | Lung | 1 | 2021 | 4116 | 0.260 |
Why?
| | Animals | 14 | 2025 | 38100 | 0.260 |
Why?
| | Hypertension | 1 | 2015 | 1276 | 0.250 |
Why?
| | Proteomics | 1 | 2013 | 1188 | 0.250 |
Why?
| | Receptor, Adenosine A2B | 2 | 2017 | 65 | 0.240 |
Why?
| | Maternal-Fetal Exchange | 2 | 2021 | 170 | 0.240 |
Why?
| | Nitric Oxide | 2 | 2020 | 892 | 0.220 |
Why?
| | Carnitine | 1 | 2025 | 91 | 0.220 |
Why?
| | Disease Models, Animal | 3 | 2021 | 4569 | 0.220 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2024 | 49 | 0.200 |
Why?
| | Male | 21 | 2025 | 72992 | 0.200 |
Why?
| | Infant Mortality | 1 | 2025 | 128 | 0.200 |
Why?
| | Placenta Growth Factor | 2 | 2022 | 26 | 0.200 |
Why?
| | HELLP Syndrome | 1 | 2023 | 5 | 0.200 |
Why?
| | Blood Pressure | 7 | 2020 | 1782 | 0.200 |
Why?
| | Physical Education and Training | 1 | 2003 | 70 | 0.200 |
Why?
| | Neonatal Screening | 1 | 2025 | 179 | 0.190 |
Why?
| | Phenylephrine | 2 | 2020 | 74 | 0.190 |
Why?
| | Europe | 5 | 2019 | 421 | 0.190 |
Why?
| | Ion Channels | 1 | 2023 | 129 | 0.190 |
Why?
| | Glucose | 2 | 2025 | 1048 | 0.190 |
Why?
| | Baroreflex | 3 | 2020 | 57 | 0.180 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5992 | 0.180 |
Why?
| | Geography | 3 | 2011 | 187 | 0.180 |
Why?
| | Amino Acids | 3 | 2023 | 519 | 0.180 |
Why?
| | Muscle, Skeletal | 5 | 2023 | 1791 | 0.180 |
Why?
| | Task Performance and Analysis | 1 | 2003 | 198 | 0.180 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2022 | 78 | 0.180 |
Why?
| | Mice | 7 | 2021 | 18357 | 0.180 |
Why?
| | Longitudinal Studies | 3 | 2019 | 2967 | 0.170 |
Why?
| | Cesarean Section | 1 | 2023 | 230 | 0.170 |
Why?
| | Acetazolamide | 2 | 2011 | 26 | 0.170 |
Why?
| | Arterial Pressure | 3 | 2020 | 134 | 0.170 |
Why?
| | Acute Disease | 3 | 2013 | 1036 | 0.170 |
Why?
| | Abortion, Spontaneous | 2 | 2020 | 119 | 0.170 |
Why?
| | Postpartum Period | 1 | 2024 | 373 | 0.170 |
Why?
| | Running | 1 | 2003 | 233 | 0.170 |
Why?
| | Phosphorylation | 3 | 2021 | 1708 | 0.170 |
Why?
| | Cardiovascular System | 2 | 2024 | 139 | 0.160 |
Why?
| | Pedigree | 2 | 2020 | 515 | 0.160 |
Why?
| | Ventricular Pressure | 1 | 2021 | 52 | 0.160 |
Why?
| | Hyperbaric Oxygenation | 1 | 2021 | 39 | 0.160 |
Why?
| | Mammals | 1 | 2022 | 286 | 0.160 |
Why?
| | Biomarkers | 4 | 2017 | 4302 | 0.160 |
Why?
| | Blood Volume | 3 | 2017 | 65 | 0.160 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5921 | 0.160 |
Why?
| | Frailty | 1 | 2023 | 205 | 0.160 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.160 |
Why?
| | Myometrium | 1 | 2020 | 38 | 0.150 |
Why?
| | Prevalence | 2 | 2025 | 2874 | 0.150 |
Why?
| | Genomics | 2 | 2023 | 831 | 0.150 |
Why?
| | Inflammation | 1 | 2011 | 2883 | 0.150 |
Why?
| | Geographic Mapping | 1 | 2019 | 26 | 0.150 |
Why?
| | Pulmonary Artery | 2 | 2015 | 1129 | 0.150 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 21 | 0.150 |
Why?
| | Thiazolidinediones | 1 | 2020 | 143 | 0.140 |
Why?
| | Dexamethasone | 2 | 2011 | 365 | 0.140 |
Why?
| | Genetics, Population | 2 | 2010 | 217 | 0.140 |
Why?
| | Nitric Oxide Synthase | 1 | 2019 | 234 | 0.140 |
Why?
| | Gene Expression | 1 | 2023 | 1478 | 0.140 |
Why?
| | Ventricular Function, Right | 1 | 2021 | 297 | 0.140 |
Why?
| | Adenosine | 2 | 2017 | 255 | 0.140 |
Why?
| | Protein Kinases | 1 | 2020 | 312 | 0.140 |
Why?
| | Peroneal Nerve | 1 | 2017 | 18 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 426 | 0.130 |
Why?
| | Puberty | 1 | 2019 | 137 | 0.130 |
Why?
| | Maternal Health Services | 1 | 2019 | 101 | 0.130 |
Why?
| | Trophoblasts | 1 | 2019 | 218 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 19 | 0.130 |
Why?
| | Time Factors | 5 | 2017 | 7133 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2025 | 1244 | 0.120 |
Why?
| | Epigenomics | 1 | 2017 | 117 | 0.120 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 630 | 0.120 |
Why?
| | Body Mass Index | 1 | 2025 | 2447 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 450 | 0.120 |
Why?
| | Heart Rate | 5 | 2020 | 856 | 0.120 |
Why?
| | Colorado | 3 | 2019 | 4556 | 0.120 |
Why?
| | Sphingosine | 1 | 2016 | 47 | 0.120 |
Why?
| | Autonomic Pathways | 1 | 2015 | 2 | 0.120 |
Why?
| | Lysophospholipids | 1 | 2016 | 80 | 0.110 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1723 | 0.110 |
Why?
| | Pulmonary Gas Exchange | 1 | 2015 | 116 | 0.110 |
Why?
| | California | 1 | 2017 | 473 | 0.110 |
Why?
| | Pregnancy Complications, Cardiovascular | 2 | 2024 | 85 | 0.110 |
Why?
| | Blood Glucose | 1 | 2025 | 2344 | 0.110 |
Why?
| | Double-Blind Method | 3 | 2011 | 2064 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 849 | 0.110 |
Why?
| | Pulmonary Veins | 1 | 2015 | 108 | 0.110 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 306 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 330 | 0.100 |
Why?
| | Receptor, Endothelin A | 1 | 2014 | 60 | 0.100 |
Why?
| | Aromatase | 1 | 2014 | 37 | 0.100 |
Why?
| | Ultrasonography, Prenatal | 4 | 2024 | 295 | 0.100 |
Why?
| | Biological Transport | 2 | 2019 | 424 | 0.100 |
Why?
| | Parity | 3 | 2018 | 111 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2019 | 497 | 0.100 |
Why?
| | Tibet | 4 | 2017 | 23 | 0.100 |
Why?
| | Homeostasis | 2 | 2014 | 644 | 0.100 |
Why?
| | Incidence | 2 | 2018 | 2933 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 574 | 0.090 |
Why?
| | Ultrasonography, Doppler | 3 | 2020 | 126 | 0.090 |
Why?
| | Congenital Abnormalities | 2 | 1991 | 109 | 0.090 |
Why?
| | Prospective Studies | 3 | 2022 | 8075 | 0.090 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 956 | 0.090 |
Why?
| | Delivery, Obstetric | 2 | 2011 | 160 | 0.090 |
Why?
| | Regression Analysis | 3 | 2018 | 1001 | 0.090 |
Why?
| | Body Height | 1 | 2013 | 203 | 0.090 |
Why?
| | Glycolysis | 3 | 2021 | 340 | 0.090 |
Why?
| | Healthy Volunteers | 3 | 2017 | 219 | 0.090 |
Why?
| | Prenatal Diagnosis | 2 | 1991 | 196 | 0.090 |
Why?
| | Polysomnography | 1 | 2013 | 239 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 592 | 0.090 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2011 | 14 | 0.090 |
Why?
| | Apgar Score | 1 | 2011 | 22 | 0.090 |
Why?
| | Hypoxia, Brain | 1 | 2011 | 9 | 0.080 |
Why?
| | Risk Factors | 6 | 2019 | 10916 | 0.080 |
Why?
| | Mountaineering | 1 | 2011 | 36 | 0.080 |
Why?
| | Estrogens | 1 | 2014 | 367 | 0.080 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2011 | 35 | 0.080 |
Why?
| | Brain Edema | 1 | 2011 | 62 | 0.080 |
Why?
| | Exercise | 2 | 2023 | 2203 | 0.080 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 544 | 0.080 |
Why?
| | Lactic Acid | 2 | 2023 | 295 | 0.080 |
Why?
| | Angiostatic Proteins | 1 | 2010 | 4 | 0.080 |
Why?
| | Angiogenic Proteins | 1 | 2010 | 15 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2011 | 330 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1101 | 0.080 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 572 | 0.080 |
Why?
| | Headache | 1 | 2011 | 152 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2017 | 5428 | 0.080 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 1068 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 160 | 0.080 |
Why?
| | Anthropology, Physical | 1 | 2009 | 24 | 0.080 |
Why?
| | Sheep | 2 | 2023 | 876 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2010 | 238 | 0.070 |
Why?
| | Fetal Diseases | 1 | 1991 | 194 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2022 | 17322 | 0.070 |
Why?
| | Adolescent | 4 | 2019 | 22569 | 0.070 |
Why?
| | Cohort Studies | 3 | 2020 | 6032 | 0.070 |
Why?
| | Fetal Blood | 1 | 2011 | 327 | 0.070 |
Why?
| | Up-Regulation | 1 | 2011 | 848 | 0.070 |
Why?
| | Age Factors | 2 | 2019 | 3346 | 0.070 |
Why?
| | South America | 3 | 2014 | 56 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2010 | 389 | 0.070 |
Why?
| | Genome, Human | 1 | 2010 | 422 | 0.070 |
Why?
| | HIV Infections | 1 | 2023 | 3195 | 0.070 |
Why?
| | Prognosis | 1 | 2017 | 4329 | 0.070 |
Why?
| | Chronic Disease | 1 | 2013 | 1810 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 478 | 0.060 |
Why?
| | Head | 1 | 2008 | 123 | 0.060 |
Why?
| | Rest | 2 | 2019 | 126 | 0.060 |
Why?
| | Urban Health | 1 | 2007 | 96 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2016 | 32 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 49 | 0.060 |
Why?
| | Indians, South American | 3 | 2013 | 23 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 81 | 0.060 |
Why?
| | Femur | 1 | 2008 | 254 | 0.060 |
Why?
| | Health Status | 1 | 2011 | 835 | 0.060 |
Why?
| | Blood Flow Velocity | 3 | 2013 | 421 | 0.060 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2007 | 107 | 0.060 |
Why?
| | Haplotypes | 2 | 2017 | 500 | 0.060 |
Why?
| | Cold Temperature | 2 | 2017 | 206 | 0.050 |
Why?
| | Maternal Age | 2 | 2018 | 128 | 0.050 |
Why?
| | Indians, North American | 1 | 2009 | 598 | 0.050 |
Why?
| | Umbilical Arteries | 1 | 2024 | 52 | 0.050 |
Why?
| | Mental Health | 1 | 2011 | 796 | 0.050 |
Why?
| | Reticulocyte Count | 1 | 2003 | 7 | 0.050 |
Why?
| | Receptors, Transferrin | 1 | 2003 | 28 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 528 | 0.050 |
Why?
| | Down Syndrome | 1 | 1991 | 525 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 23 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1777 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 240 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 109 | 0.050 |
Why?
| | Body Weight | 1 | 2007 | 972 | 0.050 |
Why?
| | Cytokines | 1 | 2010 | 2069 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2013 | 6084 | 0.050 |
Why?
| | Serine | 1 | 2023 | 143 | 0.050 |
Why?
| | Glycine | 1 | 2023 | 186 | 0.040 |
Why?
| | Potassium Channels | 1 | 2022 | 148 | 0.040 |
Why?
| | Gene Frequency | 2 | 2014 | 489 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 51 | 0.040 |
Why?
| | Developing Countries | 1 | 2023 | 317 | 0.040 |
Why?
| | Blood Gas Analysis | 2 | 2014 | 82 | 0.040 |
Why?
| | Amniocentesis | 2 | 1991 | 20 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2020 | 12 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 11 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 2 | 2019 | 119 | 0.040 |
Why?
| | Ribonucleotides | 1 | 2020 | 26 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 500 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 67 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 117 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 3130 | 0.040 |
Why?
| | Acetylcholine | 1 | 2020 | 209 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2020 | 150 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2020 | 330 | 0.030 |
Why?
| | Accelerometry | 1 | 2019 | 118 | 0.030 |
Why?
| | Genotype | 2 | 2014 | 1857 | 0.030 |
Why?
| | Renin | 1 | 2017 | 33 | 0.030 |
Why?
| | Evoked Potentials, Motor | 1 | 2017 | 52 | 0.030 |
Why?
| | Ultrasonography | 2 | 2014 | 788 | 0.030 |
Why?
| | Arginine Vasopressin | 1 | 2017 | 44 | 0.030 |
Why?
| | Aldosterone | 1 | 2017 | 42 | 0.030 |
Why?
| | Genome-Wide Association Study | 2 | 2017 | 1430 | 0.030 |
Why?
| | Recruitment, Neurophysiological | 1 | 2017 | 40 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2017 | 168 | 0.030 |
Why?
| | Ferritins | 1 | 2017 | 70 | 0.030 |
Why?
| | Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 15 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2016 | 55 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 119 | 0.030 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 49 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 125 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 60 | 0.030 |
Why?
| | Child | 2 | 2019 | 22738 | 0.030 |
Why?
| | Posture | 1 | 2017 | 197 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 302 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 180 | 0.030 |
Why?
| | Purines | 1 | 2016 | 187 | 0.030 |
Why?
| | Arginine | 1 | 2016 | 264 | 0.030 |
Why?
| | Diastole | 1 | 2015 | 146 | 0.030 |
Why?
| | Vagus Nerve | 1 | 2015 | 92 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1547 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 762 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 370 | 0.030 |
Why?
| | Receptor, Endothelin B | 1 | 2014 | 43 | 0.030 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 48 | 0.030 |
Why?
| | Insulin | 1 | 2025 | 2516 | 0.030 |
Why?
| | Action Potentials | 1 | 2017 | 502 | 0.030 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2013 | 48 | 0.020 |
Why?
| | Evaluation Studies as Topic | 2 | 1991 | 164 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 473 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2013 | 37 | 0.020 |
Why?
| | Radial Artery | 1 | 2013 | 75 | 0.020 |
Why?
| | Infant | 2 | 2020 | 10089 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 307 | 0.020 |
Why?
| | Gonadal Steroid Hormones | 1 | 2014 | 143 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2110 | 0.020 |
Why?
| | Metabolome | 1 | 2016 | 391 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1973 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2014 | 371 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2969 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 849 | 0.020 |
Why?
| | Obstetric Labor, Premature | 1 | 1992 | 39 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2190 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 319 | 0.020 |
Why?
| | Pregnancy, High-Risk | 1 | 1991 | 13 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2011 | 31 | 0.020 |
Why?
| | Exercise Test | 1 | 2014 | 630 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 456 | 0.020 |
Why?
| | Globins | 1 | 2010 | 21 | 0.020 |
Why?
| | Iliac Artery | 1 | 2011 | 55 | 0.020 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2010 | 27 | 0.020 |
Why?
| | Live Birth | 1 | 2011 | 81 | 0.020 |
Why?
| | Aged | 2 | 2023 | 26212 | 0.020 |
Why?
| | Stillbirth | 1 | 2011 | 82 | 0.020 |
Why?
| | Pregnancy Proteins | 1 | 2010 | 36 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2010 | 80 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2010 | 207 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2010 | 188 | 0.020 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 253 | 0.020 |
Why?
| | Prenatal Care | 1 | 1992 | 309 | 0.020 |
Why?
| | Intestinal Neoplasms | 1 | 1968 | 30 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2010 | 310 | 0.020 |
Why?
| | Anticonvulsants | 1 | 2011 | 246 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2011 | 610 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 298 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1300 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1454 | 0.020 |
Why?
| | Radiotherapy | 1 | 1968 | 206 | 0.020 |
Why?
| | Models, Biological | 1 | 2015 | 1764 | 0.020 |
Why?
| | Insurance, Health | 1 | 1990 | 311 | 0.020 |
Why?
| | Heart Rate, Fetal | 1 | 2007 | 31 | 0.020 |
Why?
| | Infant, Premature | 1 | 1992 | 620 | 0.020 |
Why?
| | Biometry | 1 | 2007 | 66 | 0.020 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 74 | 0.020 |
Why?
| | Lymphoma | 1 | 1968 | 241 | 0.020 |
Why?
| | Carcinoma | 1 | 1968 | 227 | 0.020 |
Why?
| | Premature Birth | 1 | 2011 | 390 | 0.020 |
Why?
| | Phylogeny | 1 | 2010 | 917 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2010 | 779 | 0.010 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1968 | 195 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 36297 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1991 | 2000 | 0.010 |
Why?
| | Patient Selection | 1 | 1990 | 739 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2933 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1218 | 0.010 |
Why?
| | Cognition | 1 | 2014 | 1271 | 0.010 |
Why?
| | Uterine Cervical Neoplasms | 1 | 1968 | 268 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2017 | 8346 | 0.010 |
Why?
| | Heart Failure | 1 | 2017 | 2326 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 1990 | 883 | 0.010 |
Why?
| | Lower Extremity | 1 | 2007 | 445 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2399 | 0.010 |
Why?
| | France | 2 | 1992 | 40 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3752 | 0.010 |
Why?
| | Educational Status | 2 | 1992 | 470 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 11793 | 0.010 |
Why?
| | Hospitals, Maternity | 1 | 1992 | 4 | 0.010 |
Why?
| | Fathers | 1 | 1992 | 53 | 0.010 |
Why?
| | Marriage | 1 | 1992 | 121 | 0.000 |
Why?
| | Occupations | 1 | 1990 | 51 | 0.000 |
Why?
| | Social Values | 1 | 1990 | 40 | 0.000 |
Why?
| | Chromosome Disorders | 1 | 1990 | 47 | 0.000 |
Why?
| | Religion | 1 | 1990 | 65 | 0.000 |
Why?
| | Personal Autonomy | 1 | 1990 | 60 | 0.000 |
Why?
| | Resource Allocation | 1 | 1990 | 52 | 0.000 |
Why?
| | Chromosome Aberrations | 1 | 1990 | 166 | 0.000 |
Why?
| | Culture | 1 | 1990 | 124 | 0.000 |
Why?
| | Estriol | 1 | 1968 | 6 | 0.000 |
Why?
| | Pregnancy Trimester, Second | 1 | 1989 | 84 | 0.000 |
Why?
| | Chorionic Gonadotropin | 1 | 1968 | 78 | 0.000 |
Why?
| | Social Class | 1 | 1990 | 264 | 0.000 |
Why?
| | Ileum | 1 | 1968 | 112 | 0.000 |
Why?
| | Risk | 1 | 1990 | 923 | 0.000 |
Why?
| | Smoking | 1 | 1992 | 1477 | 0.000 |
Why?
|
|
Julian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|